Article

Thoughts on transition to bimanual phaco

For the past few years, the lure of ever smaller incisions has enticed cataract surgeons who perform temporal, clear corneal phacoemulsification with topical anesthesia. With a variety of shooters, we have been placing IOLs through 2.5- to 2.8-mm incisions and we feel comfortable with our self-sealing wounds and good results. Still, as many of us recall with previous transitions in our cataract surgery development, taking on a new skill requires stepping out of one's comfort zone to take advantage of even better technology. Such has been the situation with bimanual phacoemulsification.

As proposed by those who taught the transition to phacoemulsification in the 1980s, it is imperative to have a plan that allows many opportunities to revert back to a more familiar technique when one feels uncomfortable. The original "Three Steps to Phaco," pioneered by William Maloney, MD, David Dilman, MD, and I. Howard Fine, MD, allowed an entire generation of surgeons performing extracapsular cataract extraction to take on a different set of surgical skills in a predictable manner. A similar approach can be taken as bimanual phacoemulsification is adopted.

1. In the transition, plan on performing bimanual irrigation/aspiration (I/A) only after removal of nucleus with a standard sleeved phaco-tip technique. Get used to the two-handed feel of the instruments.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.